UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Legacy Wealth Management LLC MS

Legacy Wealth Management LLC MS decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 8,491 shares of the healthcare conglomerate’s stock after selling 175 shares during the period. UnitedHealth Group accounts for 1.8% of Legacy Wealth Management LLC MS’s portfolio, making the stock its 12th largest position. Legacy Wealth Management LLC MS’s holdings in UnitedHealth Group were worth $4,965,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. 1ST Source Bank increased its position in UnitedHealth Group by 5.6% during the 3rd quarter. 1ST Source Bank now owns 1,687 shares of the healthcare conglomerate’s stock worth $986,000 after purchasing an additional 90 shares in the last quarter. Garden State Investment Advisory Services LLC raised its stake in shares of UnitedHealth Group by 8.4% during the third quarter. Garden State Investment Advisory Services LLC now owns 1,137 shares of the healthcare conglomerate’s stock valued at $668,000 after purchasing an additional 88 shares during the period. Copley Financial Group Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $786,000. Oddo BHF Asset Management Sas purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $44,742,000. Finally, Inspire Trust Co. N.A. increased its stake in shares of UnitedHealth Group by 2.8% in the third quarter. Inspire Trust Co. N.A. now owns 9,102 shares of the healthcare conglomerate’s stock worth $5,322,000 after buying an additional 251 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.8 %

Shares of UnitedHealth Group stock traded up $4.23 on Friday, hitting $519.99. The company had a trading volume of 2,813,929 shares, compared to its average volume of 3,962,921. The firm has a market capitalization of $478.54 billion, a P/E ratio of 33.60, a P/E/G ratio of 1.57 and a beta of 0.58. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a 50-day moving average of $583.29 and a 200-day moving average of $559.30. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.56 earnings per share. Research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.62%. UnitedHealth Group’s payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. UBS Group reduced their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald boosted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $626.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.